These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression. Pham NL; Franzen A; Levin EG Arterioscler Thromb Vasc Biol; 2004 May; 24(5):982-7. PubMed ID: 15044208 [TBL] [Abstract][Full Text] [Related]
3. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514 [TBL] [Abstract][Full Text] [Related]
4. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903 [TBL] [Abstract][Full Text] [Related]
5. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352 [TBL] [Abstract][Full Text] [Related]
7. Regulation of plasminogen activator activity and expression by cyclic mechanical stress in rat mandibular condylar chondrocytes. Chen W; Tang Y; Zheng M; Jiang J; Zhu G; Liang X; Li M Mol Med Rep; 2013 Oct; 8(4):1155-62. PubMed ID: 23982192 [TBL] [Abstract][Full Text] [Related]
8. Effects of two complex hemodynamic stimulation profiles on hemostatic genes in a vessel-like environment. Bergh N; Ulfhammer E; Karlsson L; Jern S Endothelium; 2008; 15(5-6):231-8. PubMed ID: 19065314 [TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol. Huang L; Shi Y Chin Med J (Engl); 2001 Jun; 114(6):628-31. PubMed ID: 11780441 [TBL] [Abstract][Full Text] [Related]
10. Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system. Chen PR; Lee CC; Chang H; Tsai CE J Nutr Biochem; 2005 Jan; 16(1):59-64. PubMed ID: 15629242 [TBL] [Abstract][Full Text] [Related]
11. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928 [TBL] [Abstract][Full Text] [Related]
12. Induction of the urokinase plasminogen activator system by oncostatin M promotes endothelial migration. Strand K; Murray J; Aziz S; Ishida A; Rahman S; Patel Y; Cardona C; Hammond WP; Savidge G; Wijelath ES J Cell Biochem; 2000 Aug; 79(2):239-48. PubMed ID: 10967551 [TBL] [Abstract][Full Text] [Related]
13. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor. Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628 [TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 gene expression in cultured mouse Sertoli cells. Liu YX; Du Q; Hu ZY; Tor N Sci China B; 1993 Mar; 36(3):319-28. PubMed ID: 8397803 [TBL] [Abstract][Full Text] [Related]
15. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis. Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782 [TBL] [Abstract][Full Text] [Related]
16. Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model. Tran ND; Schreiber SS; Fisher M J Cereb Blood Flow Metab; 1998 Dec; 18(12):1316-24. PubMed ID: 9850144 [TBL] [Abstract][Full Text] [Related]
17. Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent. Gingras D; Nyalendo C; Di Tomasso G; Annabi B; Béliveau R Biochem Biophys Res Commun; 2004 Jul; 320(1):205-12. PubMed ID: 15207722 [TBL] [Abstract][Full Text] [Related]
18. Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury. Yamanaka H; Obata K; Fukuoka T; Dai Y; Kobayashi K; Tokunaga A; Noguchi K Neuroscience; 2005; 132(1):183-91. PubMed ID: 15780477 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. Calin-Jageman IE; Wang J; Bannon MJ J Neurochem; 2006 Apr; 97(1):255-64. PubMed ID: 16515544 [TBL] [Abstract][Full Text] [Related]
20. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]